首页 >
法规速递
-
国家药监局药审中心关于办公地址搬迁有关事宜的通知-2023/7/31
2023-08-02查看详情 > -
国家药监局综合司公开征求《中药标准管理专门规定（征求意见稿）》意见-2024/2/5
2024-03-12查看详情 > -
Document: List of centrally authorised products with safety-related changes to the product information-2025/1/31
2025-02-05查看详情 > -
Document: Minutes of the Cancer Medicines Forum - December 2024-2025/3/11
2025-03-12查看详情 > -
Document: Superseded - Composition of the Emergency Task Force (ETF) for preparedness-2025/4/11
2025-04-13查看详情 > -
Document: Timetable: Type IB variation requiring linguistic review-2025/5/23
2025-05-26查看详情 > -
Page: Tadalafil product-specific bioequivalence guidance-2025/6/30
2025-07-01查看详情 > -
Document: List of changes to combined Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) list of clinical terms for reporting suspected adverse events in animal and humans to veterinary medicinal products for 2025-2025/7/31
2025-08-01查看详情 > -
国家药监局综合司公开征求《国家药监局关于深化化妆品监管改革促进产业高质量发展的意见 （征求意见稿）》意见-2025/9/19
2025-09-22查看详情 > -
关于将盐酸阿思尼布片/胶囊装微片纳入《儿童抗肿瘤药物研发鼓励试点计划（星光计划）》试点项目的公示-2025/10/27
2025-10-28查看详情 >
